Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus, according to a study in Nicaragua of more than 3,000 children aged 2 to 14 years.
Advertisements
Uncategorized
African Economic Outlook 2019: Africa growth prospects remain steady, industry should lead growth
Africa’s general economic performance continues to recover and GDP growth is projected to accelerate to 4.0 percent in 2019 and 4.1 percent in 2020.
Ten threats to global health in 2019
The world is facing multiple health challenges. These range from outbreaks of vaccine-preventable diseases like measles and diphtheria, increasing reports of drug-resistant pathogens, growing rates of obesity and physical inactivity to the health impacts of environmental pollution and climate change and multiple humanitarian crises.
Clinical Trial Testing Fecal Microbiota Transplant for Recurrent Diarrheal Disease Begins
A research consortium recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema—putting stool from a healthy donor in the colon of a recipient—is safe and can prevent recurrent Clostridium difficile-associated disease (CDAD), a potentially life-threatening diarrheal illness.
AfDB and UTB signed agreement to support women-owned businesses and SMEs in Sierra Leone
The African Development Bank signed a 5-year, US $3-million Line of Credit (LoC) with Sierra Leone’s Union Trust Bank (UTB), the only indigenous private bank in Sierra Leone and an important provider of finance for indigenous micro, small and medium-sized enterprises.
NIH study implicates hyperactive immune system in aging brain disorders
In a study of fruit flies, NIH scientists suggested that the body’s immune system may play a critical role in the damage caused by aging brain disorders.
NIH researcher presents encouraging results for gene therapy for severe sickle cell disease
A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease.
